showed a trendP = 0.755
They also found that the combination of SBRT with sorafenib showed a trend toward prolonged median OS (16.6 months versus 10.9 months, P = 0.755), but no statistical difference was observed.
They also found that the combination of SBRT with sorafenib showed a trend toward prolonged median OS (16.6 months versus 10.9 months, P = 0.755), but no statistical difference was observed.
The pooled effect size showed a trend towards reducing total cholesterol levels in the biologic treatment group (MD = -0.03, 95% CI: [-0.21, -0.15], P = 0.76), (z = 0.30, P = 0.76).
In contrast, there was a statistically significant male predominance in the subgroup of patients with SM-AHN, whereas patients with ASM and MCL showed a trend towards male predominance (ASM, 52%, p = 0.77; SM-AHN, 70%, p < 0.001; MCL, 58%, p = 0.360).
Similarly, patients of HIVLD having APOB 12669AA and 12669GA genotypes in the presence of impaired triglyceride level showed a trend of risk for severity of HIVLD (P = 0.77, OR = 2.91; P = 0.25, OR = 3.64).
Just like in the EPM also the NSF confirmed enhanced anxiety in 5-HT 1A (-/-) knockout mice, time spent in the center of the arena (Wt = 27.32±3.81s, 1A-ko = 17.57±2.6s, p = 0.042) is significantly decreased and time till feeding showed a trend towards longer waiting times (Wt 118.56±19.16s, 1A-ko 146.69±36.67s, p = 0.772) ( S1F and S1G Fig ).
Ventral forebrain volume ( Figure 1 d) at E14 showed a trend decrease with RS (F1,20=3.451, p=0.780) and sex-stress interaction for FS (F1,18=6.986, p=0.0165, post hoc NS vs FS males p=0.0106), while at E18, a trend increase with CUS (F1,17=3.737, p=0.0700) and trend sex-stress interaction with effects opposite those at E14 with FS (F1,22=3.284, p=0.08080).
Although no significant differences were detected, the JBT group showed a trend of a lower rate in MI (6.3 vs. 7.1%, p = 0.79), target lesion revascularization (TLR, 1.4 vs. 2.1%, p = 0.68), and MACE a composite of all-cause death (MI, or TLR, 8.4 vs. 10.6%, p = 0.52, Figure 3 ) than the JWT group.
Physical demand ( p = 0.125) and temporal demand ( p = 0.21) showed a trend to differ between conditions, whereas the other components did not ( p > 0.79).
By contrast, the DI group showed a trend for better ORR ( Figure 3 ) and mPFS ( Figure 5A ) than those of the PI, DnI, and PnI groups (ORRs: 47.5%, 43.2%, 33.3%, and 40.5%, respectively, p = 0.799; and mPFS: 378, 190, 170, and 172 days, respectively, p = 0.115), though the differences were not statistically significant.
From the first to the second TACE cycle, most of the tumorous lesions ( n = 28, 89%) showed a trend to decrease in size (from 22.3 ± 17.0 to 21.2 ± 25.2 cm 2 , p = 0.8) (see Fig. 3 ), whereas cancer stiffness significantly increased in all lesions from 5.8 ± 1.2 to 6.9 ± 1.4 kPa ( p = 0.002) (see Fig. 4 ).
They showed a trend toward superior efficacy in diagnosis of gastric and duodenal adenoma for pCLE compared with non-magnifying NBI ( P = 0.8), (sensitivity 92 % vs. 83 %, specificity 78 % vs. 78 %, PPV 71 % vs. 69 %, NPV 94 % vs. 89 % and accuracy 83 % vs. 80 %) 24 With the improvement in image quality plus dual focus function of the new NBI, the current study demonstrated much higher efficacy for dNBI in diagnosis of duodenal adenoma compare to conventional NBI.
CyERV Env expression (r = −0.17; n = 9; P = 0.67) showed a trend towards a negative association ( Fig. 5C ) in comparison with gag expression (r = 0.11; n = 8; P = 0.80), which displayed a trend towards a positive association ( Fig. 5D ).
However, it was not associated with superior late survival for patients aged 66 years and above at the time of CABG, and showed a trend to harm among octogenarians (HR 1.05, 95% CI 0.70-1.56, p = 0.80).
T cell responses in the intake group, however, showed a trend towards higher S activated CD8 + T cell frequencies (T FH p=0.802, T H p=0.802, CD8 + p=0.235).
In a Danish observational study, 53% of AF patients took more than five drugs/day ( 45 ), while an analysis of the ROCKET AF study showed that 36% of patients were on 0 to 4 medications, 51% were on 5 to 9, 13% were on ≥10; patients taking ≥10 medications daily were older and showed a trend toward a higher bleeding risk (HR 1.46, 95% CI [1.29-1.64], p = 0.81) ( 46 ).
Concomitant use of a higher number of medications (>10 medications) showed a trend toward increased risk of major and minor bleeding (HR 1.46, 95% CI [1.29–1.64], P =0.81) but not stroke and systemic thromboembolism when compared to use of 0–4 medications. 65 Another cross-sectional study from the Danish anticoagulation clinic reported that 53% of patients used ≥5 prescription me
Patients with GC showed a trend toward better prognosis (p=0.812) (Figure 5C ).
While GLP-1 RAs showed a trend towards reducing all-cause mortality (OR = 0.90, 95% CI: 0.82–98, I 2 = 40%; moderate, IV) (Egger’s test P = 0.818), they significantly reduced the risk of CVD mortality (OR = 0.88, 95% CI: 0.70–97, I 2 = 18%; moderate, IV) (Egger’s test P = 0.624).
The complete non-responders showed a trend toward even higher rates of intrapartum cesarean delivery (36.36% vs 30.77%, P = 0.819).
This study found that patients who experienced SHAEs showed a trend toward worse PFS than those without SHAEs (median 13.0, IQR 0.0-38.4 months vs median 24.0, IQR 19.2-28.8 months; P =.82); although no statistically significant difference was found, these toxicities still require early detection and proper management.
The findings indicated that exercise-based physical activity persistently showed a trend toward reducing the HRpeak or HRmax (WMD = −1.42, 95% CI: −13.92 to 11.07, P = .82), with high heterogeneity (I 2 = 79%, P = .002), as shown in Supplemental Table 6 .
Those treated with FOLFOX showed a trend towards longer median OS relative to FOLFIRI (36.0 vs. 22.6 months, HR 0.91, 95% CI: 0.32 to 2.4, p = 0.83) but the difference did not reach statistical significance.
Pedunculopontine nucleus functional connectivity changes after exercise Exercise significantly increased the overall right PPN connectivity ( Figure 5A , p = 0.02) but showed a trend of decreasing the overall PPN connectivity on the left side ( Figure 5A , p = 0.83).
Although hearing gain at 2 years showed a trend toward better outcomes in Stage 1, this difference was not statistically significant ( p = 0.830) ( Table 9 ). 4.
Inhibition of CoQ synthesis through 4‐NB treatment caused a significant increase in TST and SUOX mRNA transcript levels (200 and 168% of controls; P = 0.02 and P = 0.04), and showed a trend toward an increase in SQR and ETHE1 mRNA transcript levels (127 and 158% of controls; P = 0.84 and P = 0.15; Fig EV3 A).